peptide platform

Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch
Endpoints
Mon, 08/1/16 - 09:44 am
Allergan
David Pyott
biotech
Takeda
Bioniz
peptide platform